Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | March 28, 2024 04:31pm

Gainers

  • Qilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. The company's market cap stands at $39.3 million.
  • Sunshine Biopharma (NASDAQ:SBFM) shares increased by 37.85% to $0.08. The market value of their outstanding shares is at $8.2 million.
  • Dare Bioscience (NASDAQ:DARE) stock rose 12.19% to $0.55. The company's market cap stands at $54.2 million. As per the news, the Q4 earnings report came out today.
  • Xilio Therapeutics (NASDAQ:XLO) shares moved upwards by 9.36% to $1.2. The company's market cap stands at $33.0 million.
  • Talphera (NASDAQ:TLPH) stock rose 8.73% to $1.12. The market value of their outstanding shares is at $19.0 million.
  • Zentalis Pharma (NASDAQ:ZNTL) shares increased by 8.62% to $17.12. The company's market cap stands at $1.2 billion.

Losers

  • Vivos Therapeutics (NASDAQ:VVOS) stock fell 12.6% to $4.22 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million. As per the news, the Q4 earnings report came out today.
  • Cartesian Therapeutics (NASDAQ:RNAC) stock declined by 12.31% to $0.57. The market value of their outstanding shares is at $92.3 million.
  • Pulse Biosciences (NASDAQ:PLSE) stock decreased by 11.37% to $7.72. The company's market cap stands at $425.2 million. The company's, Q4 earnings came out today.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 9.27% to $1.47. The market value of their outstanding shares is at $6.2 million.
  • BiomX (AMEX:PHGE) stock fell 8.89% to $0.41. The company's market cap stands at $18.8 million.
  • Iridex (NASDAQ:IRIX) stock decreased by 8.28% to $2.77. The company's market cap stands at $45.0 million. As per the news, the Q4 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BDRX DARE IRIX PHGE PLSE QLI RNAC SBFM TLPH VVOS XLO ZNTL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist